Related Experiment Videos
The Influenza Surveillance Program in Western Australia, 2003
Annette K Broom1, W Smith David
1The Western Australian Centre for Pathology and Medical Research, Locked Bag 2009, Nedlands, WA 6909.
Communicable Diseases Intelligence Quarterly Report
|October 6, 2004
Summary
Western Australia faced a significant influenza epidemic in 2003, peaking in August and September. Despite a vaccine mismatch, the epidemic did not disproportionately affect vaccinated individuals, including the elderly.
Area of Science:
- Epidemiology
- Virology
- Public Health
Background:
- Western Australia experienced its most substantial influenza epidemic in at least five years during the winter of 2003.
- Influenza activity peaked sharply in August and September, characterized by a short season with high case numbers during peak weeks.
Purpose of the Study:
- To analyze the characteristics of the 2003 Western Australian influenza epidemic.
- To assess the effectiveness of the influenza vaccine and identify other respiratory viruses causing influenza-like illness.
Main Methods:
- Surveillance of influenza cases through sentinel general practices and routine laboratory detections.
- Analysis of influenza virus types and subtypes, including age distribution shifts.
- Identification of other respiratory viruses co-circulating during the epidemic.
Main Results:
- Influenza A was the predominant virus (28.3% of sentinel samples), with a shift towards increased infections in children and young adults.
- The majority of influenza A isolates were A/Fujian/411/2002-like, a variant of the vaccine strain A/Moscow.
- No significant increase in influenza risk was observed in vaccinated populations, including the elderly, despite the vaccine mismatch.
- Rhinoviruses and human metapneumovirus were the most common non-influenza respiratory viruses identified.
Conclusions:
- The combination of influenza detections and increased influenza-like illness (ILI) accurately predicted the epidemic's onset.
- The 2003 influenza vaccine, despite a mismatch with circulating strains, appeared to offer protection, with no increased risk in vaccinated groups.
- Other respiratory viruses like rhinoviruses and human metapneumovirus also contributed to ILI during the epidemic.